_version_ 1784771546585235456
author Khatir, Wassila
Humbert, Olivier
Benzaquen, Jonathan
Bontoux, Christophe
Neels, Jaap
Berland, Léa
Rivera, Fabian Andrés Gallardo
Allegra, Maryline
Salah, Myriam
Tanga, Virginie
Bordone, Olivier
Fayada, Julien
Lespinet‐Fabre, Virginie
Bohly, Doriane
Long‐Mira, Elodie
Lassalle, Sandra
Vouret, Valérie
Brest, Patrick
Mograbi, Baharia
Maniel, Charlotte
Otto, Josiane
Boutros, Jacques
Heeke, Simon
Hofman, Véronique
Marquette, Charles‐Hugo
Hofman, Paul
Ilié, Marius
author_facet Khatir, Wassila
Humbert, Olivier
Benzaquen, Jonathan
Bontoux, Christophe
Neels, Jaap
Berland, Léa
Rivera, Fabian Andrés Gallardo
Allegra, Maryline
Salah, Myriam
Tanga, Virginie
Bordone, Olivier
Fayada, Julien
Lespinet‐Fabre, Virginie
Bohly, Doriane
Long‐Mira, Elodie
Lassalle, Sandra
Vouret, Valérie
Brest, Patrick
Mograbi, Baharia
Maniel, Charlotte
Otto, Josiane
Boutros, Jacques
Heeke, Simon
Hofman, Véronique
Marquette, Charles‐Hugo
Hofman, Paul
Ilié, Marius
author_sort Khatir, Wassila
collection PubMed
description
format Online
Article
Text
id pubmed-9394752
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93947522022-08-24 Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer Khatir, Wassila Humbert, Olivier Benzaquen, Jonathan Bontoux, Christophe Neels, Jaap Berland, Léa Rivera, Fabian Andrés Gallardo Allegra, Maryline Salah, Myriam Tanga, Virginie Bordone, Olivier Fayada, Julien Lespinet‐Fabre, Virginie Bohly, Doriane Long‐Mira, Elodie Lassalle, Sandra Vouret, Valérie Brest, Patrick Mograbi, Baharia Maniel, Charlotte Otto, Josiane Boutros, Jacques Heeke, Simon Hofman, Véronique Marquette, Charles‐Hugo Hofman, Paul Ilié, Marius Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2022-08-22 /pmc/articles/PMC9394752/ /pubmed/35994416 http://dx.doi.org/10.1002/ctm2.1018 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Khatir, Wassila
Humbert, Olivier
Benzaquen, Jonathan
Bontoux, Christophe
Neels, Jaap
Berland, Léa
Rivera, Fabian Andrés Gallardo
Allegra, Maryline
Salah, Myriam
Tanga, Virginie
Bordone, Olivier
Fayada, Julien
Lespinet‐Fabre, Virginie
Bohly, Doriane
Long‐Mira, Elodie
Lassalle, Sandra
Vouret, Valérie
Brest, Patrick
Mograbi, Baharia
Maniel, Charlotte
Otto, Josiane
Boutros, Jacques
Heeke, Simon
Hofman, Véronique
Marquette, Charles‐Hugo
Hofman, Paul
Ilié, Marius
Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
title Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
title_full Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
title_fullStr Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
title_full_unstemmed Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
title_short Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
title_sort identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394752/
https://www.ncbi.nlm.nih.gov/pubmed/35994416
http://dx.doi.org/10.1002/ctm2.1018
work_keys_str_mv AT khatirwassila identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT humbertolivier identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT benzaquenjonathan identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT bontouxchristophe identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT neelsjaap identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT berlandlea identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT riverafabianandresgallardo identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT allegramaryline identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT salahmyriam identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT tangavirginie identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT bordoneolivier identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT fayadajulien identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT lespinetfabrevirginie identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT bohlydoriane identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT longmiraelodie identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT lassallesandra identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT vouretvalerie identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT brestpatrick identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT mograbibaharia identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT manielcharlotte identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT ottojosiane identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT boutrosjacques identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT heekesimon identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT hofmanveronique identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT marquettecharleshugo identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT hofmanpaul identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer
AT iliemarius identificationofacirculatingimmunologicalsignaturepredictiveofresponsetoimmunecheckpointinhibitorsinpatientswithadvancednonsmallcelllungcancer